Determinants of Chronic Inflammatory Skin Disease Trajectories

Launched by UNIVERSITY HOSPITAL SCHLESWIG-HOLSTEIN · Jun 22, 2023

Keywords

ClinConnect Summary

This clinical trial, titled "Determinants of Chronic Inflammatory Skin Disease Trajectories," is studying how different factors affect the way chronic skin diseases, like atopic dermatitis, psoriasis, eczema, lichen, and alopecia areata, develop and progress over time. Researchers want to learn more about why these conditions can look and feel different for each person and hope to find specific signs that could help doctors better manage these diseases for their patients.

To participate in the trial, you need to have a skin disease diagnosed by a dermatologist and be able to give written consent. However, if you are pregnant or breastfeeding, currently involved in another clinical trial, or have recently used certain treatments like immunosuppressive therapy or specific skin creams, you won't be eligible. Participants will undergo thorough evaluations, including long-term check-ups and the collection of biological samples, to help researchers gather important information about these skin conditions. This study aims to improve understanding and treatment options for individuals with chronic inflammatory skin diseases.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • dermatologist-diagnosed inflammatory skin disease
• • informed consent
• Exclusion Criteria:
• • subject and/or the legal guardians are not able to give written informed consent
• • pregnant and breastfeeding women
• • concurrent participation in a clinical trial
• • use of systemic immunosuppressive therapy or phototherapy during the last 4 weeks or receipt of biologics therapy (e.g. dupilumab, tralokinumab) within the last 3 months
• • treatment of the target skin areas with topical corticosteroids, calcineurin inhibitors or emollients 24 hours before sample collection